Our top pick for
Blucora Inc is an asset management business based in the US. Blucora shares (BCOR) are listed on the NASDAQ and all prices are listed in US Dollars. Blucora employs 846 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$16.62|
|52-week range||$9.86 - $18.83|
|50-day moving average||$15.92|
|200-day moving average||$16.28|
|Wall St. target price||$24.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.37|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||3.04%|
|1 month (2021-09-17)||10.29%|
|3 months (2021-07-16)||2.21%|
|6 months (2021-04-16)||1.34%|
|1 year (2020-10-16)||60.58%|
|2 years (2019-10-16)||-18.85%|
|3 years (2018-10-16)||34.28|
|5 years (2016-10-14)||44.52%|
Valuing Blucora stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Blucora's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Blucora's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.59. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Blucora's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Blucora's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $144.6 million.
The EBITDA is a measure of a Blucora's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$863.2 million|
|Operating margin TTM||12.49%|
|Gross profit TTM||$356.7 million|
|Return on assets TTM||6.61%|
|Return on equity TTM||-4.63%|
|Market capitalisation||$785.1 million|
TTM: trailing 12 months
There are currently 1.1 million Blucora shares held short by investors – that's known as Blucora's "short interest". This figure is 3.4% up from 1.1 million last month.
There are a few different ways that this level of interest in shorting Blucora shares can be evaluated.
Blucora's "short interest ratio" (SIR) is the quantity of Blucora shares currently shorted divided by the average quantity of Blucora shares traded daily (recently around 193352.30769231). Blucora's SIR currently stands at 5.85. In other words for every 100,000 Blucora shares traded daily on the market, roughly 5850 shares are currently held short.
However Blucora's short interest can also be evaluated against the total number of Blucora shares, or, against the total number of tradable Blucora shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Blucora's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Blucora shares in existence, roughly 20 shares are currently held short) or 0.0237% of the tradable shares (for every 100,000 tradable Blucora shares, roughly 24 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Blucora.
Find out more about how you can short Blucora stock.
We're not expecting Blucora to pay a dividend over the next 12 months.
Blucora's shares were split on a 1:10 basis on 12 September 2002. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Blucora shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Blucora shares which in turn could have impacted Blucora's share price.
Over the last 12 months, Blucora's shares have ranged in value from as little as $9.86 up to $18.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Blucora's is 1.6434. This would suggest that Blucora's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Blucora, Inc. provides technology-enabled financial solutions to consumers, small business owners, tax professionals, financial advisors, and certified public accounting firms in the United States. The company operates through two segments, Wealth Management and Tax Preparation. The Wealth Management segment offers an integrated platform of brokerage, investment advisory, and insurance services to financial advisors. The Tax Preparation segment provides digital do-it-yourself tax preparation solutions through TaxAct. com; and ancillary services, including refund payment transfer, audit defense, stored value cards, retirement plan services, and e-filing services. This segment also offers professional tax preparer software that allows professional tax preparers to prepare and file individual and business returns.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.